Pharming PHAR
NASDAQ PHAR
$9.65 -0.10 (-1.03%)
As of: Oct 21, 2026 · 2:25 PM EDT

Pharming (PHAR) Finished Goods (2020 - 2022)

Updated

Pharming (PHAR) recorded Finished Goods of $19.03 million in Q2 2022, up 31.1% from $14.52 million a year earlier.

Analysis

Pharming (PHAR) Finished Goods (2020 - 2022) Analysis & Trends

At the end of FY2021, Pharming reported Finished Goods of $13.56 million, up 6.4% from FY2020.

  • Across earlier years, Finished Goods came in at $12.74 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Pharming 664.67 Mn -129.70 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 19.03 Mn
Dec 31, 2021 13.56 Mn
Jun 30, 2021 14.52 Mn
Dec 31, 2020 12.74 Mn
API Access

Pharming Finished Goods API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=finished-goods&ticker=PHAR&period=max&api_key=YOUR_API_KEY